Testing and validation of bispecific antibody combinations targeting treatment-resistant cancer stem cells using organoid-based screening tools: a new drug discovery paradigm

Project Information

SUPPRESSTEM

Grant agreement ID: 601876

Project closed

Start date 1 June 2013

End date 30 November 2016

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 756 658,40

EU contribution € 5 953 319,00

Coordinated by

MERUS BV
Netherlands